A Comprehensive Review on the Ethosomes

Ethosomes, novel lipid based nanocarriers enriched with ethanol, have emerged as a promising advancement in dermal and transdermal drug delivery systems. Their unique composition, typically comprising phospholipids, ethanol, and water, imparts exceptional flexibility to vesicular membranes, enabling enhanced penetration through the stratum corneum and deeper skin layers. This property distinguishes ethosomes from conventional liposomes and other vesicular carriers, which often face limitations in delivering hydrophilic and lipophilic drugs across biological barriers. Over the past two decades, extensive research has highlighted the versatility of ethosomes in encapsulating a wide range of therapeutic agents, including synthetic drugs, phytoconstituents, peptides, and antifungal or antibacterial compounds. Their ability to improve bioavailability, sustain drug release, and reduce systemic side effects has positioned ethosomes as a valuable platform for topical and systemic therapy. The review consolidates current knowledge on ethosomal systems, focusing on their composition, preparation techniques, characterization methods, and mechanisms of skin penetration. Various preparation approaches, such as thin film hydration, cold method, and sonication, have been optimized to yield stable vesicles with high entrapment efficiency. Characterization parameters including particle size, zeta potential, entrapment efficiency, drug release kinetics, and stability studies are critical in determining the performance of ethosomal formulations. Mechanistically, ethanol disrupts lipid bilayers of the stratum corneum, while phospholipids enhance fluidity, collectively facilitating deeper drug permeation. This synergistic effect underscores the superiority of ethosomes over conventional carriers. Clinical and preclinical studies have demonstrated the therapeutic potential of ethosomes in diverse applications, ranging from anti inflammatory and antifungal treatments to cosmetic formulations and transdermal delivery of hormones or vaccines. Ethosomes have shown promise in improving patient compliance by offering non invasive, sustained, and targeted drug delivery. Furthermore, the incorporation of herbal extracts into ethosomal gels has opened new avenues for integrating traditional medicine with modern nanotechnology. Despite these advantages, challenges such as large scale production, long term stability, and regulatory standardization remain significant hurdles for commercial translation. Future perspectives emphasize the need for advanced characterization techniques, in vivo pharmacokinetic studies, and clinical trials to establish ethosomes as reliable drug delivery systems. In conclusion, ethosomes represent a revolutionary approach in nanocarrier technology, bridging the gap between conventional topical formulations and advanced transdermal systems. Their unique physicochemical properties, coupled with broad therapeutic applicability, make them a subject of growing interest in pharmaceutical research. This review provides a comprehensive overview of ethosomal systems, highlighting their potential to transform drug delivery practices and encouraging further exploration into their clinical utility.